Is vascular remodelling in patients with chronic heart failure exaggerated?

Robert Pietschner1, Agnes Bosch1, Dennis Kannenkeril1

  • 1Clinical Research Centre, Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

ESC Heart Failure
|October 4, 2022
PubMed

Insights

Vascular remodelling and function are impaired in chronic heart failure (CHF) patients, independent of risk factors. This impairment correlates with CHF severity, highlighting a significant link between vascular health and heart condition.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Heart Failure Research

Background:

  • Vascular remodelling in large arteries elevates left ventricular afterload.
  • Chronic heart failure (CHF) is associated with significant cardiovascular changes.
  • Understanding vascular impairment in CHF is crucial for patient management.

Purpose of the Study:

  • To investigate vascular remodelling and function in CHF patients.
  • To determine if impairment exists independently of cardiovascular risk factors.
  • To assess vascular changes under both laboratory and 24-hour ambulatory conditions.

Main Methods:

  • A monocentric, cross-sectional observational study.
  • 105 CHF patients (ejection fraction ≤49%) compared to 118 controls.
  • Vascular parameters assessed using pulse wave analysis (SphygmoCor) and UNEX EF device.

Main Results:

  • CHF patients showed impaired vascular function and structure compared to controls, even after adjusting for risk factors.
  • Significant differences observed in resting and 24-h pulse wave velocity (PWV), central systolic blood pressure (cSBP), and brachial intima-media thickness.
  • Higher NT-proBNP levels (CHF severity marker) correlated with increased PWV and cSBP.

Conclusions:

  • CHF patients exhibit augmented vascular remodelling and functional impairment independent of traditional risk factors.
  • The degree of vascular impairment is directly related to the severity of chronic heart failure.
  • Findings underscore the importance of addressing vascular health in CHF management.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
488
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
34
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
19
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K